Video

The importance of incorporating the patient’s voice when developing new treatments

“We need to understand what the treatment [means] to them as individuals, and how they perceive the benefit of the treatment,” says Cornelia Haag, Molkenteller, MD, PhD.

In this video, Cornelia Haag-Molkenteller, MD, PhD, discusses the takeaways of the study, “Once-daily vibegron 75 mg for overactive bladder: Long-term safety and efficacy from a double-blind extension study of the international phase 3 trial (EMPOWUR).” Haag-Molkenteller is a chief medical officer at Urovant Sciences, Inc in Irvine, California.

Related Videos
Man talking with a doctor | Image Credit: © Chinnapong - stock.adobe.com
Woman talking with a doctor | Image Credit: © Liudmila Dutko - stock.adobe.com
Rebecca A. Campbell, MD, answers a question during a Zoom video interview
Related Content
© 2025 MJH Life Sciences

All rights reserved.